Cargando…
Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients
Autores principales: | Bouzid, Donia, Kapfer, Thomas, Marot, Stéphane, Ing, Vittiaroat, Ferré, Valentine Marie, Chauvin, Anthony, Le Goff, Jérôme, Ellouze, Sami, Salmona, Maud, Hermand, Christelle, Bourg, Arthur, Schnuriger, Aurélie, Fémy, Florent, Van Tinh, Méryl Nguyen, Brichler, Ségolène, Veyer, David, Le Borgne, Pierrick, Fafi-Kremer, Samira, L'Honneur, Anne Sophie, Augustin, Clément, Simon, Tabassome, Cachanado, Marine, Freund, Yonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829437/ https://www.ncbi.nlm.nih.gov/pubmed/36634909 http://dx.doi.org/10.1016/j.cmi.2023.01.001 |
Ejemplares similares
-
Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
por: Carrazco-Montalvo, Andrés, et al.
Publicado: (2022) -
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
por: Evans, John P., et al.
Publicado: (2022) -
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
por: Ai, Jingwen, et al.
Publicado: (2022) -
Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England
por: Webster, H. H., et al.
Publicado: (2022) -
Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
por: Møller Kirsebom, Freja Cordelia, et al.
Publicado: (2022)